Companies: 10,795·Total market cap: $144.5T

Allurion Technologies Inc.

Allurion Technologies Inc.

ALUROTCHealthcare● Active

$0.74

$-0.13(-15.02%)

Market Cap$5582070

P/E Ratio—

52W High$3.33

52W Low$0.23

Avg Volume82K

Open$0.71

Beta-0.17

股票排行：Medical - Devices·Healthcare·查看全部市值排行 →

Allurion Technologies Inc.（ALUR）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ALUR · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-3.76Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$12.6MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding75.4MShares outstanding history

Next EarningsAug 18, 2026Est.Earnings history

探索 Allurion Technologies Inc. 数据

分析师预测$3 · Buy

股息不分红

营收$15.2M-52.57%

盈利EPS $-3.81+67.27%

财务快照

FY 2025Revenue$15.2M▼ 52.57% YoY

202320242025

FY 2025Net Income-$28.8M▼ 9.97% YoY

202320242025

FY 2025EPS$-3.81▲ +67.27% YoY

202320242025

TTM:Revenue: $12.6MNet Income: -$33.3MEPS: $-3.76View income statement →

分析师评级与目标价

Buy2 位分析师

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$3.00Low

$0.74Current

$3.00Avg Target上涨空间 305.41%

$3.00High

合计: 2 · 买入占比: 100.0%

根据过去 3 个月内 2 位华尔街分析师，ALUR 共识评级为 Buy，12 个月平均目标价 $3.00 （较现价 $0.74 上涨空间 305.41%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Allurion Technologies Inc.

$0.74-15.02%$5.6M #2

Adaptimmune Therapeutics plc

$0.05-3.00%$12.5M #3

Aethlon Medical, Inc.

$1.97+2.88%$1.5M #4

Envoy Medical, Inc.

$0.65-2.80%$13.5M #5

Co-Diagnostics, Inc.

$5.54-1.78%$6.2M #6

Ernexa Therapeutics Inc.

$7.58-3.93%$2.4M

股票表现

1D-15.02%

1W-3.90%

1M-5.12%

3M+10.27%

YTD-39.84%

1Y-72.69%

5Y-99.70%

关于 Allurion Technologies Inc.

CEOShantanu K. Gaur

IPO DateMar 29, 2021

Employees134

CountryUS

Websiteallurion.com

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intraga…

Medical - Devices HealthcareOTCUS

关于股票概览与关键数据

Allurion Technologies Inc.（ALUR）是 Medical - Devices 行业的 Healthcare 类公司，于 Mar 29, 2021 在 OTC 上市。截至最近交易日，ALUR 股价为 $0.74，市值约为 $5.6M。过去12个月累计回报 -72.69%，年初至今回报 -39.84%。

根据 2 位华尔街分析师，Allurion Technologies Inc. 股票共识评级为Buy，12个月平均目标价为 $3.00。2025 财年 Allurion Technologies Inc. 营收 $15.2M，净利润 -$28.8M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Allurion Technologies Inc.（ALUR）股价为 $0.74，在 OTC 上市，52周区间为 $0.23 – $3.33。

ALUR 最新股价ALUR quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议